People with MEN2 are born with a faulty (i.e., disease-causing) RET gene.
When working properly, the RET gene provides instructions to produce a protein involved in signalling within cells. This signalling is needed to ensure normal development and controlled growth of cells.
If there is a fault (i.e., mutation) within the RET gene, it can become dysfunctional, resulting in the production of an overactive protein which can signal cells to grow and divide uncontrollably, resulting in tumour formation and cancer.
The location of the fault within the RET gene can determine the age, likelihood and aggressiveness of the medullary thyroid cancer that may develop. Its management will be based on where the location of the fault is in the RET gene.
Note: The conditions associated with a faulty RET gene and their risk estimates may change as more information is available.
Depending on your genetic result and personal/family history of cancer, your personal risk levels may differ from the values shown above.
There is a classification system that determines the medullary thyroid cancer risk level based on where the fault in the RET gene is located. It is best to ask your genetics service to understand your risk level in more detail.
Your managing doctors will also advise you on the medical care that might or might not be beneficial for you, according to your risk level.
MEN2 follows a dominant inheritance pattern. This means that having one faulty copy of the RET gene can result in an increased risk of tumours/cancer. It affects both males and females.
Everyone has 2 copies of each gene in their body’s cells:
Subscribe to our mailing list to get the updates to your inbox